{
    "complex": true,
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "replication_method": "synthetic",
    "ucits": false,
    "type": "ETP",
    "complex_factors": [
        "Leverage (2x daily)",
        "Synthetic replication using swaps",
        "Daily compounding effect",
        "Counterparty risk from swap agreements",
        "Non-UCITS structure",
        "High risk profile (7/7)",
        "Short-term holding recommendation (1 day)"
    ],
    "classification": "complex",
    "supporting_data": "The WisdomTree FTSE 100 2x Daily Leveraged ETP is classified as complex under MiFID II due to several key factors: 1) It uses synthetic replication through swap agreements, which introduces counterparty risk; 2) The product employs 2x daily leverage, which creates compounding effects and magnified risk; 3) The recommended holding period is only 1 day, making it unsuitable for long-term investors; 4) The product has a risk rating of 7/7, indicating very high risk; 5) While UCITS-eligible, the product is not UCITS-compliant in its current structure; 6) The fact sheet explicitly states that the product is 'only intended for sophisticated and/or informed investors' and warns about the risks of daily compounding and leverage. The combination of these factors makes the product complex under MiFID II regulations, even though it is fully collateralized. The use of derivatives here goes beyond efficient portfolio management and fundamentally alters the risk profile of the investment.",
    "confidence": 95
}